Prepare for the Drug Discovery and Healthcare Systems Test. Access flashcards and multiple-choice questions with hints and explanations. Ace your exam with our comprehensive resources!

Multiple Choice

What is the purpose of Phase IV post-marketing surveillance?

Phase IV post-marketing surveillance is about watching how a drug performs in the real world after it has been approved, with a focus on safety over the long term. Once a drug is available to a broad population, it’s used by people with varying ages, health conditions, and other medications, which can reveal adverse effects or safety concerns not seen in the controlled trials. This ongoing monitoring helps teams detect rare or long-term risks, assess real-world effectiveness, and guide updates to labeling and risk-management strategies. Initial dosing and safety are typically established in earlier-phase trials, not after approval. In vitro drug interaction studies are done in laboratory or early clinical settings, not during post-marketing surveillance. Regulatory submissions are prepared and filed before approval, not as Phase IV activities aimed at monitoring afterward.

Phase IV post-marketing surveillance is about watching how a drug performs in the real world after it has been approved, with a focus on safety over the long term. Once a drug is available to a broad population, it’s used by people with varying ages, health conditions, and other medications, which can reveal adverse effects or safety concerns not seen in the controlled trials. This ongoing monitoring helps teams detect rare or long-term risks, assess real-world effectiveness, and guide updates to labeling and risk-management strategies.

Initial dosing and safety are typically established in earlier-phase trials, not after approval. In vitro drug interaction studies are done in laboratory or early clinical settings, not during post-marketing surveillance. Regulatory submissions are prepared and filed before approval, not as Phase IV activities aimed at monitoring afterward.